Across TCGA pan-cancer cohorts, UCK1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated UCK1 data layer compared with 25 for mass-spec protein and 3 for mutation status.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher UCK1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated UCK1 expression acts as an unfavorable survival marker, although some lineages such as CCRCC and PDAC show a favorable association.
HNSC, CCRCC, and PDAC are the cancer types where UCK1 mass-spec protein most reproducibly stratifies survival.